About 100 reports

  • Increase in incidence of pulmonary hypertension (PH)
  • 66 GLOBAL PULMONARY ARTERIAL HYPERTENSION DRUGS MARKET 2017-2021

About Pulmonary Arterial Hypertension (PAH) Drugs PAH in the arteries, which carry blood from the heart to the lungs, occurs when blood vessels become narrow, making blood flow difficult. Technavio’s analysts forecast the global pulmonary arterial hypertension drugs market to grow at a CAGR of 3.2% during the period 2017-2021. Covered...

  • Hypertension
  • Actelion Ltd
  • Daiichi Sankyo Company
  • Novartis AG
  • United Therapeutics Corporation
  • Hypertension Drugs Industry Structure
  • Other Hypertension Drugs

China’s demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...

  • Hypertension
  • China
  • Demand
  • AstraZeneca China Inc.
  • Sanofi-Synthelabo Inc.
  • PATHOPHYSIOLOGY OF HYPERTENSION
  • Overview: Hypertension

About Hypertension Drugs Hypertension, or high blood pressure (BP), develops when there is too much pressure against the inner walls of blood vessels. Depending on the pressure exerted, hypertension can be classified as: - PAH - Systemic hypertension (commonly referred to as hypertension) PAH, high BP in the arteries...

  • Hypertension
  • Actelion Ltd
  • AstraZeneca PLC
  • Daiichi Sankyo Company
  • Sanofi S.A.
  • Other Hypertension Drugs
  • Other Hypertension Drugs

This study focuses on China’s Hypertension Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Hypertension
  • China
  • Demand
  • Trade
  • AstraZeneca China Inc.
  • Pulmonary Arterial Hypertension: Executive Summary
  • 4.1 BIBLIOGRAPHY

EpiCast Report: Pulmonary Arterial Hypertension - Epidemiology Forecast to 2026 Summary Pulmonary arterial hypertension (PAH) is a rare and severe condition characterized by vascular proliferation and remodeling of the small pulmonary arteries. This results in progressively increasing pulmonary vascular...

  • Hypertension
  • France
  • Japan
  • United States
  • Forecast
  • Systemic hypertension
  • PULMONARY ARTERIAL HYPERTENSION KEY METRICS IN THE 7MM

OpportunityAnalyzer: Pulmonary Arterial Hypertension - Opportunity Analysis and Forecasts to 2026 Summary Pulmonary arterial hypertension (PAH) is a rare, fatal cardiopulmonary disease with an annual mortality rate of 15%. The disease is a subset (Group 1) within the World Health Organization’s (WHO’s)...

  • Hypertension
  • Therapy
  • United States
  • Actelion Ltd
  • United Therapeutics Corporation
  • Global pulmonary hypertension market: 2014-2019 ($ billions)
  • Strength

About pulmonary hypertension Pulmonary hypertension is a rare disorder that affects the pulmonary arteries carrying deoxygenated blood to the lungs from the heart. The narrowing or blockage of pulmonary arteries will lead to pulmonary hypertension. Symptoms of the disease do not occur until the disease becomes severe. Certain causes of...

  • Hypertension
  • United States
  • Actelion Ltd
  • Bayer AG
  • United Therapeutics Corporation
  • Hypertension Drugs Sales Volume
  • Hypertension Drugs Industry Structure

This study focuses on China’s Hypertension Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China...

  • Hypertension
  • China
  • AstraZeneca China Inc.
  • Hangzhou MSD Pharmaceutical Co., Ltd
  • Sanofi-Synthelabo Inc.
  • ANTI-HYPERTENSIVE THERAPEUTICS, TREATMENT ALGORITHM OF HYPERTENSION
  • ANTI-HYPERTENSIVE THERAPEUTICS, DEFINITIONS OF HYPERTENSION BY OFFICE AND OUT-OF-

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline Summary Hypertension is a serious and common medical condition characterized by elevated blood pressure. It is commonly seen in the aging population, and in people with sedentary...

  • Hypertension
  • World
  • Market Size
  • Daiichi Sankyo Company
  • Novartis AG

Global Hypertension Epidemiology and Patient Flow Analysis - 2017 ##.

  • Hypertension
  • France
  • United States
  • World
  • Forecast

Global Plumonary Arterial Hypertension Epidemiology and Patient Flow Analysis - 2017 ##.

  • Hypertension
  • France
  • United States
  • World
  • Forecast
  • Classification of hypertension
  • TOP-LINE PREVALENCE FOR HYPERTENSION

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hypertension in 19 Major Markets Hypertension (high blood pressure) is a common condition in which the force of the blood against the artery walls is high enough that it may eventually cause serious health problems. These health problems include heart...

  • Chronic Disease
  • Hypertension
  • Pathology
  • Increasing incidence of hypertension coupled with geriatric population
  • Identifying factors impacting market growth

About Digital Blood Pressure Monitors Digital blood pressure monitors are used to detect, record, and diagnose blood pressure. These digital blood pressure monitors are used in home care settings, clinics, hospitals, and ambulatory surgery centers. Technavio’s analysts forecast the global digital blood pressure...

  • Hypertension
  • United States
  • World
  • Forecast
  • Omron Corporation

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Hypertension
  • France
  • United States
  • Market Shares
  • Market Size

Pulmonary Hypertension Phase ## Clinical Trials, 2016 ##.

  • Hypertension
  • France
  • United States
  • Market Shares
  • Market Size

Europe Hypertension Epidemiology and Patient Flow Analysis - 2017 ##.

  • Hypertension
  • Europe
  • France
  • Germany
  • Forecast

2018 Essential Hypertension Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Essential Hypertension Market ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Essential Hypertension Pipeline Analysis ##. ##

  • Chronic Disease
  • Hypertension

2018 Idiopathic Hypertension Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Idiopathic Hypertension Market ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Idiopathic Hypertension Pipeline Analysis

  • Chronic Disease
  • Hypertension
  • Increasing incidence of hypertension coupled with geriatric population
  • monitoring the person's blood pressure accurately. It is highly useful in evaluating white coat hypertension or masked hypertension.

About Ambulatory Blood Pressure Monitoring Systems Ambulatory blood pressure monitoring (ABPM) systems are superior testing devices to monitor and record a person’s blood pressure accurately. The device measures blood pressure for 24 hrs and provides valuable diagnostic information. Technavio’s analysts forecast...

  • Blood Device
  • Healthcare
  • Hemodynamic Monitor
  • Hospital
  • Hypertension

Europe Plumonary Arterial Hypertension Epidemiology and Patient Flow Analysis - 2017 ##.

  • Hypertension
  • Europe
  • France
  • Germany
  • Italy

Drug A: Company ## ##. ##. ##.

  • Chronic Disease
  • Hypertension
  • United States
  • Market Shares

Global Pulmonary Arterial Hypertension Epidemiology and Patient Flow Analysis - 2016 ##.

  • Hypertension
  • France
  • United States
  • World
  • Forecast

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Hypertension
  • France
  • Germany
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • United States
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • Japan
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • Germany
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • Italy
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • United Kingdom
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • France
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • Spain
  • Market Shares
  • Market Size